¼¼°èÀÇ 3D ÃÊÀ½ÆÄ ½ÃÀå
3D Ultrasound
»óǰÄÚµå : 1777710
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 380 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,186,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,559,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

3D ÃÊÀ½ÆÄ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 53¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 36¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â 3D ÃÊÀ½ÆÄ ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 6.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 53¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠīƮ/Æ®·Ñ¸® 3D ÃÊÀ½ÆÄ´Â CAGR 7.7%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 33¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ Á¦Ç° À¯Çü ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 4.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 9¾ï 8,590¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR10.4%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ 3D ÃÊÀ½ÆÄ ½ÃÀåÀº 2024³â¿¡ 9¾ï 8,590¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 11¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 10.4%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.1%¿Í 6.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.2%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è 3D ÃÊÀ½ÆÄ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

3D ÃÊÀ½ÆÄ°¡ ¿µ»óÁø´Ü¿¡¼­ ¼±È£µÇ´Â ¿µ»óÁø´Ü¹ýÀ¸·Î ¶°¿À¸£´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

3D ÃÊÀ½ÆÄ´Â ÀÌ¿ÂÈ­ ¹æ»ç¼±À» »ç¿ëÇÏÁö ¾Ê°íµµ º¼·ý ºä, ½Ç½Ã°£ Ç¥¸é ·»´õ¸µ, °íÇØ»óµµ ÇØºÎÇÐÀû ½Ã°¢È­¸¦ Á¦°øÇÒ ¼ö Àֱ⠶§¹®¿¡ ¿µ»ó Áø´Ü ºÐ¾ß¿¡¼­ ºü¸£°Ô º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ºñħ½ÀÀû ¿µ»ó ±â¼úÀ» ÅëÇØ ÀÓ»óÀÇ´Â Àå±â, Á¶Á÷, ÅÂ¾Æ ±¸Á¶ÀÇ 3Â÷¿ø À籸¼ºÀ» ÃÔ¿µÇÒ ¼ö ÀÖ¾î »êºÎÀΰú, ½ÉÀåÇÐ, Á¾¾çÇÐ, ±Ù°ñ°Ý°è ÀÇÇÐ µî ´Ù¾çÇÑ Àü¹® ºÐ¾ß¿¡¼­ Áø´Ü Á¤È®µµ¿Í ½Ã¼úÀÇ ½Å·Ú¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. 3D ¿µ»óÀº ÀÛ¾÷ÀÚÀÇ ÇØ¼®ÀÌ ÇÊ¿äÇÑ ±âÁ¸ 2D ÃÊÀ½ÆÄ °Ë»ç¿Í ´Þ¸®, º¸´Ù Á÷°üÀûÀÌ°í °ø°£ÀûÀ¸·Î Á¤È®ÇÑ ³»ºÎ ÇØºÎÇÐÀû ¹¦»ç¸¦ Á¦°øÇÏ¿© ÀÌ»ó ¼Ò°ßÀÇ ¼±¸íµµ¸¦ ³ôÀ̰í Ä¡·á °èȹÀ» Áö¿øÇÕ´Ï´Ù. »êºÎÀΰú ¿µ¿ª¿¡¼­ 3D ÃÊÀ½ÆÄ´Â ÅÂ¾Æ ÀÌ»ó °Ë»ç, ¾È¸é Àç°Ç, Àڱà ºÎÇÇ ÃøÁ¤ÀÇ ÁÖ·ù µµ±¸·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. Á¾¾çÇп¡¼­´Â Á¾¾ç ±¹¼Ò Áø´Ü, »ý°Ë °èȹ, Ä¡·á È¿°ú ÃßÀû¿¡ äÅõǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁßÀçÀû ½Ã¼ú, ¼ö¼ú °¡À̵å, Àç°Ç¿ë ¿µ»óÁø´Ü¿¡¼­µµ ±× ¿ªÇÒÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀº ÃÖ¼ÒÇÑÀÇ À§Çè°ú ÀçÇö¼ºÀ» °®Ãá °íǰÁú ½Ç½Ã°£ ¿µ»óÀ» Á¡Á¡ ´õ ¸¹ÀÌ ¿ä±¸Çϰí ÀÖÀ¸¸ç, 3D ÃÊÀ½ÆÄ´Â Á¢±Ù¼º°ú ¿µ»ó Áø´ÜÀÇ °íµµÈ­ »çÀÌÀÇ °£±ØÀ» ¸Þ¿ï ¼ö ÀÖ´Â °­·ÂÇÑ Áø´Ü ¸ð´Þ¸®Æ¼·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀÌ È­Áú, Á¢±Ù¼º, ¿öÅ©Ç÷οì ÅëÇÕÀ» ¾î¶»°Ô °³¼±Çϰí Àִ°¡?

±â¼ú Çõ½ÅÀº 3D ÃÊÀ½ÆÄÀÇ ±Þ¼ÓÇÑ ½ÃÀå ¹ßÀüÀÇ ÇÙ½ÉÀ̸ç, ÇØ»óµµ, ÃÔ¿µ ¼Óµµ, µðÁöÅÐ ÇコÄɾî ȯ°æÀ¸·ÎÀÇ ÅëÇÕÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. °íÁÖÆÄ Æ®·£½ºµà¼­, ¸ÅÆ®¸¯½º ¾î·¹ÀÌ ÇÁ·Îºê, ¼ÒÇÁÆ®¿þ¾î ±â¹Ý ºö Æ÷¹ÖÀº ¾ÆÆ¼ÆÑÆ®¸¦ ÁÙÀÌ°í º¸´Ù ¼±¸íÇÏ°í »ó¼¼ÇÑ Ã¼Àû À籸¼ºÀ» ½ÇÇöÇÕ´Ï´Ù. ½Ç½Ã°£ 3D(¶Ç´Â 4D) ÃÊÀ½ÆÄ´Â ƯÈ÷ ÅÂ¾Æ ¸ð´ÏÅ͸µ ¹× ½ÉÃÊÀ½ÆÄ °Ë»ç¿¡¼­ üÀû ¿µ»ó¿¡ ½Ã°£Àû Â÷¿øÀ» Ãß°¡ÇÏ´Â °ÍÀ¸·Î, ÇöÀç ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. AI¿Í ¸Ó½Å·¯´×¿¡ ÀÇÇÑ °í±Þ ÈÄó¸® ¾Ë°í¸®ÁòÀº ÀÚµ¿ ÃøÁ¤, À̹ÌÁö °­È­, ÀÌ»ó °ËÃâÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ÀÛ¾÷ÀÚÀÇ ÀÇÁ¸µµ¿Í °Ë»ç ½Ã°£À» Å©°Ô ÁÙ¿´½À´Ï´Ù. È޴뼺µµ Çâ»óµÇ¾î ¿Ü·¡ Áø·á¼Ò, Áö¹æ ÀÇ·á ¼¾ÅÍ, À̵¿ Áø´Ü À¯´Ö¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â ¼ÒÇü īƮÇü ¹× ÇÚµåÇïµåÇü 3D ÃÊÀ½ÆÄ ½Ã½ºÅÛÀÌ ½ÃÀå¿¡ Ãâ½ÃµÇ°í ÀÖ½À´Ï´Ù. PACS ½Ã½ºÅÛ, EMR, ¿ø°Ý¿µ»óÁø´Ü Ç÷§Æû°úÀÇ ¿øÈ°ÇÑ ÅëÇÕÀ» ÅëÇØ ¿ø°ÝÁø·á, ¼¼ÄÁµå ¿ÀÇǴϾð, ´ÙÁ÷Á¾ ÇùÁøÀ» Áö¿øÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ½ºÅ丮Áö¿Í À̹ÌÁö °øÀ¯ ±â´ÉÀº µ¥ÀÌÅÍ¿¡ ´ëÇÑ Á¢±Ù¼º°ú ȯÀÚ Á᫐ Áø·á ¸ðµ¨À» ´õ¿í °­È­ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº º¸´Ù ±¤¹üÀ§ÇÑ ÀÓ»ó ÇöÀå¿¡¼­ ¹Þ¾Æµé¿©Áö°í ÀÖÀ¸¸ç, ½Ç½Ã°£ µ¥ÀÌÅÍ¿¡ ±â¹ÝÇÑ Áø´ÜÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù.

3D ÃÊÀ½ÆÄÀÇ º¸±ÞÀ» µÞ¹ÞħÇÏ´Â ÀÓ»ó ¹× ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

¿¹¹æÀÇÇÐ, Á¤¹ÐÀÇÇÐ, ÃÖ¼Òħ½ÀÀû Ä¡·á·ÎÀÇ ÀüȯÀº ¿©·¯ ºÐ¾ß¿¡¼­ 3D ÃÊÀ½ÆÄ¸¦ ¼±È£µÇ´Â ¿µ»ó ¾ç½ÄÀ¸·Î äÅÃÇÏ´Â °è±â°¡ µÇ°í ÀÖ½À´Ï´Ù. »êºÎÀΰú¿¡¼­´Â žÆÀÇ ¹ßÀ°, ÀÚ±ÃÀÇ ÀÌ»ó, Àڱà ³» ±â±¸ÀÇ Æò°¡¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ½ÉÀå Àü¹®ÀǵéÀº ½É½Ç, ÆÇ¸· ÇüÅÂ, ¼±ÃµÀû °áÇÔÀ» ½Ã°¢È­Çϱâ À§ÇØ 3D ½ÉÃÊÀ½ÆÄ¸¦ »ç¿ëÇϰí ÀÖÀ¸¸ç, 2D ¿µ»óº¸´Ù Á¤È®µµ°¡ Çâ»óµÇ¾ú½À´Ï´Ù. Á¤Çü¿Ü°ú³ª ½ºÆ÷Ã÷ ÀÇÇп¡¼­´Â ¹æ»ç¼±À» Á¶»çÇÏÁö ¾Ê°íµµ ¿ªµ¿ÀûÀÎ ±Ù°ñ°Ý°è Æò°¡¸¦ ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ¾Ï, ½ÉÇ÷°üÁúȯ, ³»ºÐºñÁúȯ µî ¸¸¼ºÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¶±â ¹ß°ß, Ä¡·á °èȹ, Àå±â ¸ð´ÏÅ͸µÀ» Áö¿øÇÏ´Â ¿µ»óÁø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡, ¿µ»ó À¯µµ »ý°Ë, Ä«Å×ÅÍ »ðÀÔ, ¼ö¼ú Áß ÀÀ¿ë ºÐ¾ß¿¡¼­ ½Ç½Ã°£ ½Ã°¢È­ÀÇ Çʿ伺ÀÌ ¼ö¼ú½Ç°ú ÁßÀçÀû Ä¡·á½Ç¿¡¼­ 3D ÃÊÀ½ÆÄÀÇ ÀÓ»óÀû »ç¿ëÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ ¼ö Áõ°¡, ÀÇ»çÀÇ ¾÷¹«·® Áõ°¡, °í±Þ ¿µ»ó 󸮿¡ ´ëÇÑ »óȯ Áö¿ø µî ½ÃÀå ¿ªÇеµ 3D äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ¼Ò¾Æ°ú ¹× »êÀü Áø´Ü¿¡¼­ ¹æ»ç¼±À» »ç¿ëÇÏÁö ¾Ê´Â Áø´ÜÀ» ¼±È£Çϴ ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó 3D ÃÊÀ½ÆÄ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

3D ÃÊÀ½ÆÄ ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇÏ´Â ÀÓ»ó ºÎ¹® ¹× ¼¼°è Áö¿ªº° ¼ºÀå µ¿·ÂÀº ¹«¾ùÀΰ¡?

3D ÃÊÀ½ÆÄ ½ÃÀåÀÇ ¼ºÀåÀº ÇコÄɾîÀÇ µðÁöÅÐÈ­, ÀÓ»ó ¼ö¿ä, Àα¸ Åë°èÇÐÀû º¯È­ µî ¿©·¯ °¡Áö »óÈ£ ¿¬°üµÈ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Ãâ»êÀ² Áõ°¡¿Í »êÀü °Ë»ç ÇÁ·Î±×·¥ÀÇ È®´ë·Î ÀÎÇØ »ê¸ð¿Í žÆÀÇ ÀÇ·á¿¡ 3D ¿µ»ó µµÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ÅÈï °æÁ¦±¹¿¡¼­´Â °í·ÉÈ­°¡ ÁøÇàµÇ¸é¼­ ½ÉÀ庴ÇÐ, Á¾¾çÇп¡¼­ Áúº´ÀÇ Á¶±â ¹ß°ß ¹× ½Ã¼ú Áöµµ¸¦ À§ÇÑ ÀÌ¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶ó°¡ È®´ëµÇ°í ÈÞ´ë¿ë ÃÊÀ½ÆÄ ±â¼úÀÇ ÁøÀÔÀ庮ÀÌ ³·¾ÆÁü¿¡ µû¶ó ÀÌ¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì¿Í À¯·´¿¡¼­´Â Áø·á °¡À̵å¶óÀο¡ 3D ÃÊÀ½ÆÄ°¡ Æ÷ÇԵǴ µî ±Þ¿© Á¤Ã¥ÀÌ µÞ¹ÞħµÇ¸é¼­ º´¿ø°ú ¿Ü·¡¿¡¼­ÀÇ µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. 3D ÃÊÀ½ÆÄÀÇ ÇöÀå Áø´Ü, ÁßȯÀÚ½Ç, ÀÀ±Þ½Ç µî°úÀÇ ÅëÇÕÀ¸·Î 3D ÃÊÀ½ÆÄÀÇ Àû¿ë ¹üÀ§°¡ ´õ¿í È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »óÈ£¿î¿ë¼ºÀ» ³ôÀ̰í ÀÓ»ó ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϱâ À§ÇÑ OEM, ¼ÒÇÁÆ®¿þ¾î Á¦°ø¾÷ü, ÀÇ·á ±â°ü°úÀÇ Àü·«Àû Á¦ÈÞµµ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© Àü ¼¼°è ÀÇ·á ÇöÀå¿¡¼­ Á¤È®¼º, È޴뼺, ½Ã¼úÀÇ À¯¿ë¼ºÀÇ ±ÕÇüÀ» Á¦°øÇÏ´Â Â÷¼¼´ë ¿µ»ó ÃÔ¿µ ¸ð´Þ¸®Æ¼·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(īƮ/Æ®·Ñ¸® 3D ÃÊÀ½ÆÄ, ±âŸ Á¦Ç° À¯Çü), ¿ëµµ(»êºÎÀΰú ¿ëµµ, ºñ´¢±â°ú ¿ëµµ, ÀÏ¹Ý ¿µ»ó ¿ëµµ, ¼øÈ¯±â°ú ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø ÃÖÁ¾ ¿ëµµ, ¿µ»óÁø´Ü¼¾ÅÍ ÃÖÁ¾ ¿ëµµ, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global 3D Ultrasound Market to Reach US$5.3 Billion by 2030

The global market for 3D Ultrasound estimated at US$3.6 Billion in the year 2024, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Cart / Trolley 3D Ultrasound, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Other Product Types segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$985.9 Million While China is Forecast to Grow at 10.4% CAGR

The 3D Ultrasound market in the U.S. is estimated at US$985.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 10.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global 3D Ultrasound Market - Key Trends & Drivers Summarized

Why Is 3D Ultrasound Gaining Ground as the Preferred Modality in Diagnostic Imaging?

3D ultrasound is rapidly expanding its footprint in diagnostic imaging due to its ability to provide volumetric views, real-time surface rendering, and high-resolution anatomical visualization without ionizing radiation. This non-invasive imaging technique enables clinicians to capture three-dimensional reconstructions of organs, tissues, and fetal structures, enhancing diagnostic precision and procedural confidence across specialties such as obstetrics, cardiology, oncology, and musculoskeletal medicine. Unlike traditional 2D ultrasound, which requires significant operator interpretation, 3D imaging delivers a more intuitive and spatially accurate depiction of internal anatomy, improving the clarity of abnormal findings and aiding in treatment planning. In obstetrics, 3D ultrasound has become a mainstream tool for fetal anomaly screening, facial reconstruction, and uterine volume measurement. In oncology, it is being adopted for tumor localization, biopsy planning, and therapy response tracking. Its role is also expanding in interventional procedures, surgical guidance, and reconstructive imaging. As healthcare providers increasingly demand high-quality, real-time imaging with minimal risk and repeatability, 3D ultrasound is emerging as a powerful diagnostic modality that bridges the gap between accessibility and imaging sophistication.

How Are Technology Innovations Improving Image Quality, Accessibility, and Workflow Integration?

Technological innovation is at the core of 3D ultrasound’s rapid market evolution, driving improvements in resolution, acquisition speed, and integration across digital healthcare environments. High-frequency transducers, matrix array probes, and software-based beamforming are delivering sharper, more detailed volumetric reconstructions with reduced artifacts. Real-time 3D (or 4D) ultrasound, which adds a temporal dimension to volumetric imaging, is now widely available, particularly in fetal monitoring and echocardiography. Advanced post-processing algorithms powered by AI and machine learning are enabling automated measurements, image enhancement, and anomaly detection, significantly reducing operator dependency and examination time. Portability is also improving, with compact, cart-based, and handheld 3D ultrasound systems now entering the market, making it feasible for use in outpatient clinics, rural health centers, and mobile diagnostic units. Seamless integration with PACS systems, EMRs, and tele-imaging platforms is supporting remote consultations, second opinions, and multidisciplinary collaboration. Cloud-based storage and image sharing capabilities are further enhancing data accessibility and patient-centric care models. These advancements are driving broader clinical acceptance and enabling real-time, data-rich diagnostics in a wider range of healthcare settings.

What Are the Clinical and Market Drivers Supporting Widespread 3D Ultrasound Adoption?

The shift toward preventive care, precision medicine, and minimally invasive procedures is catalyzing the adoption of 3D ultrasound as a preferred imaging modality across multiple disciplines. In obstetrics and gynecology, it is used extensively for evaluating fetal development, uterine anomalies, and intrauterine devices. Cardiologists use 3D echocardiography to visualize cardiac chambers, valve morphology, and congenital defects, offering improved accuracy over 2D imaging. In orthopedics and sports medicine, it facilitates dynamic musculoskeletal assessments without the need for radiation exposure. The growing burden of chronic diseases, including cancer, cardiovascular conditions, and endocrine disorders, is driving demand for imaging tools that can support early detection, procedural planning, and longitudinal monitoring. Simultaneously, the need for real-time visualization in image-guided biopsies, catheter placements, and intraoperative applications is expanding the clinical use of 3D ultrasound in operating rooms and interventional suites. Market dynamics such as rising patient volumes, increased physician workloads, and reimbursement support for advanced imaging procedures are also favoring 3D adoption. Additionally, growing patient preference for radiation-free diagnostics, especially in pediatric and prenatal care, is reinforcing demand for 3D ultrasound solutions.

What Is Driving the Growth of the 3D Ultrasound Market Across Clinical Segments and Global Regions?

The growth in the 3D ultrasound market is driven by several interrelated factors spanning healthcare digitalization, clinical demand, and demographic shifts. Rising birth rates and expanded prenatal screening programs are increasing the adoption of 3D imaging in maternal-fetal medicine. The aging population in developed economies is prompting higher utilization in cardiology and oncology for early disease detection and procedural guidance. Emerging markets are seeing increased uptake as healthcare infrastructure expands and portable ultrasound technologies lower the barrier to entry. Supportive reimbursement policies in North America and Europe, along with the inclusion of 3D ultrasound in clinical practice guidelines, are accelerating adoption in hospital and ambulatory care settings. The integration of 3D ultrasound in point-of-care diagnostics, critical care, and emergency response units is further widening its application spectrum. Growth is also supported by strategic collaborations between OEMs, software providers, and healthcare institutions to enhance interoperability and streamline clinical workflows. Collectively, these drivers are positioning 3D ultrasound as a next-generation imaging modality that offers a balance of precision, portability, and procedural utility across the global healthcare landscape.

SCOPE OF STUDY:

The report analyzes the 3D Ultrasound market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Cart/Trolley 3D Ultrasound, Other Product Types); Application (Obstetrics and Gynecology Application, Urology Application, General Imaging Application, Cardiology Application, Other Applications); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â